 CAMBRIDGE, Mass., May 31, 2021 GLOBE NEWSWIRE -- Constellation Pharmaceuticals, Inc. Nasdaq: CNST, a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that the Company will participate in an upcoming virtual investor conference. Jigar Raythatha, president and chief executive officer, will present at the Jefferies Virtual Healthcare Conference at 3:00 PM EDT on June 3. Live audio webcast of Mr. Raythathas presentation and archives for replay will be available on the Investor Relations section of Constellations website at The audio webcast replays will be available for 90 days following the live presentation. 